Asset Publisher

All programs on board in 2019 for RI-MUHC Summer Student Research Day

Congratulations to students who contributed to the scientific life of our institute this summer!

The Centre for Outcomes Research and Evaluation’s third Annual Research Day was a success!

The May 14 event organized by the Centre for Outcomes Research and Evaluation (CORE) provided an opportunity for trainees from all eight RI-MUHC programs to share their work and discoveries.

$27.9M to develop novel therapeutics options for patients with cancer

RI-MUHC is part of a Quebec-wide collaborative effort to provide oncology innovation and discovery pipeline

Patient empowerment app Opal wins Prix d'excellence honour

Technology and patient insight at the heart of innovative patient portal developed at the MUHC

Recognizing great ideas at the McGill Clinical Innovation Competition

Congratulations to two winning teams from the RI-MUHC: BetaSense and Antibiotic Sentinel!

Two RI-MUHC early-career researchers explore new frontiers

David Labbé and Géraldine Merle are in the inaugural cohort awarded funding from the New Frontiers in Research Fund from the Canadian government

Hope on the horizon for hard-to-treat breast cancers

Unique multi-party collaboration forged to develop new anti-cancer therapies targeting DNA repair regulators

Four RI-MUHC grad students land top federal funding

Four graduate students from the Research Institute of the McGill University Health Centre (RI-MUHC) are among the 16 from McGill to win 2019 Vanier Scholarships.

Harnessing the body’s power in fight against cancer

Immunotherapy has provided lung cancer patients with real hope of recovery

Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell

The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.

What’s new at the 2019 Cancer Research Program (CRP) Research Day?

Along with traditional presentations, the first CRP 3-minute thesis competition!

Predicting Breast Cancer Metastasis to the Lung and Liver with Biomarkers

RI-MUHC researcher Peter Siegel and research associate Sébastien Tabariès have identified a key component of breast cancer metastasis to the liver and lung

Rising to the 3-Minute Thesis challenge

Zeinab Sharifi, doctoral student at the RI-MUHC, advances to the regional level with her first-prize placement at McGill

Three RI-MUHC teams receive funding from the CFI and Government of Quebec

Funding will “provide our researchers with the foundational infrastructure needed to become leading-edge contributors in diverse research fields,” says Martha Crago

Focus on McGill Nursing Faculty: Christine Maheu shares her passion for cancer survivorship care and research

“My research is focused on programs to help cancer survivors cope with uncertainty and fear of recurrence along with support in the return to work”

RI-MUHC Team Wins Québec Science's 2018 People's Choice Award for Discovery of the Year

A reliable test for early detection of endometrial and ovarian cancers wins Québec Science’s 2018 Award for Discovery of the Year!

Shared genetic marker offers new promise in targeting specific ovarian and lung cancers

Two new papers offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer

McGill paper wins journal award

A research paper describing a texture-based model that predicts lung metastasis risk in soft-tissue sarcomas won its authors the...

Quebec researchers among recipients of $34 million “Grand Challenge” Grant from Cancer Research UK to combat cancer

Research teams from McGill and MUHC are part of an international effort to uncover how chronic inflammation causes cancer

See Archive - Cancer